---
document_datetime: 2023-09-21 18:29:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/amglidia-epar-all-authorised-presentations_en.pdf
document_name: amglidia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.911883
conversion_datetime: 2025-12-28 15:47:07.315362
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                       |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------------------------------------------|
| EU/1/18/1279/001 | Amglidia          | 0.6 mg/ml  | Oral suspension       | Oral use                  | bottle (glass)        | 30 ml                     | 1 bottle + 1 bottle adapter + 1 ml oral syringe |
| EU/1/18/1279/002 | Amglidia          | 0.6 mg/ml  | Oral suspension       | Oral use                  | bottle (glass)        | 30 ml                     | 1 bottle + 1 bottle adapter + 5ml oral syringe  |
| EU/1/18/1279/003 | Amglidia          | 6 mg/ml    | Oral suspension       | Oral use                  | bottle (glass)        | 30 ml                     | 1 bottle + 1 bottle adapter + 1ml oral syringe  |
| EU/1/18/1279/004 | Amglidia          | 6 mg/ml    | Oral suspension       | Oral use                  | bottle (glass)        | 30 ml                     | 1 bottle + 1 bottle adapter + 5ml oral syringe  |